BOESS CARSTEN
CIK: 0001277495•SVP, Chief Financial Officer
OfficerDirector
Primary company: INSULET CORP (PODD)
BOESS CARSTEN is a corporate insider (SVP, Chief Financial Officer) at INSULET CORP (PODD) filing SEC Form 4 transactions. 224 transactions across 6 companies, totaling $217,822 in purchases and $18,320,575 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 64,860 | $3.35 | $217K | 64,860 | 6/18/2026 Filed: 6/18/2026 | Filing → | |
| Award | 22,862 | - | - | 52,862 | 6/18/2026 Filed: 6/18/2026 | Filing → | |
| Award | 30,000 | - | - | 30,000 | 6/18/2025 Filed: 7/18/2025 | Filing → | |
| Award | 10,034 | - | - | 10,034 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Award | 6,692 | - | - | 6,692 | 6/10/2025 Filed: 6/12/2025 | Filing → | |
| Award | 23,944 | - | - | 23,944 | 6/13/2024 Filed: 6/20/2024 | Filing → | |
| Award | 13,489 | - | - | 13,489 | 6/13/2024 Filed: 6/14/2024 | Filing → | |
| Award | 25,850 | $0.00 | $0 | 25,850 | 6/22/2023 Filed: 6/26/2023 | Filing → | |
| Award | 22,000 | $0.00 | $0 | 22,000 | 6/15/2023 Filed: 6/20/2023 | Filing → | |
| Award | 22,000 | $0.00 | $0 | 22,000 | 6/15/2022 Filed: 6/17/2022 | Filing → | |
| Award | 47,745 | $0.00 | $0 | 47,745 | 6/13/2022 Filed: 6/15/2022 | Filing → | |
| Award | 15,000 | $0.00 | $0 | 15,000 | 6/16/2021 Filed: 6/16/2021 | Filing → | |
| Award | 12,236 | $0.00 | $0 | 12,236 | 6/14/2021 Filed: 6/16/2021 | Filing → | |
| Award | 20,000 | $0.00 | $0 | 20,000 | 6/16/2020 Filed: 6/18/2020 | Filing → | |
| Award | 30,000 | $0.00 | $0 | 30,000 | 1/28/2019 Filed: 1/30/2019 | Filing → | |
Kiniksa Pharmaceuticals, Ltd. KNSA | Conversion | 107,050 | $0.00 | $0 | 473,035 | 5/29/2018 Filed: 5/29/2018 | Filing → |
Kiniksa Pharmaceuticals, Ltd. KNSA | Conversion | 6,392 | $0.00 | $0 | 0 | 5/29/2018 Filed: 5/29/2018 | Filing → |
Kiniksa Pharmaceuticals, Ltd. KNSA | Conversion | 107,050 | $0.00 | $0 | 0 | 5/29/2018 Filed: 5/29/2018 | Filing → |
Kiniksa Pharmaceuticals, Ltd. KNSA | Conversion | 6,392 | $0.00 | $0 | 79,589 | 5/29/2018 Filed: 5/29/2018 | Filing → |
Kiniksa Pharmaceuticals, Ltd. KNSA | Purchase | 6,392 | $15.64 | $100K | 6,392 | 2/9/2018 Filed: 5/29/2018 | Filing → |
Type
Award
Shares
64,860
Price
$3.35
Value
$217K
Type
Award
Shares
22,862
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
10,034
Price
-
Value
-
Type
Award
Shares
6,692
Price
-
Value
-
Type
Award
Shares
23,944
Price
-
Value
-
Type
Award
Shares
13,489
Price
-
Value
-
Type
Award
Shares
25,850
Price
$0.00
Value
$0
Type
Award
Shares
22,000
Price
$0.00
Value
$0
Type
Award
Shares
22,000
Price
$0.00
Value
$0
Type
Award
Shares
47,745
Price
$0.00
Value
$0
Type
Award
Shares
15,000
Price
$0.00
Value
$0
Type
Award
Shares
12,236
Price
$0.00
Value
$0
Type
Award
Shares
20,000
Price
$0.00
Value
$0
Type
Award
Shares
30,000
Price
$0.00
Value
$0
Kiniksa Pharmaceuticals, Ltd.
KNSA
Type
Conversion
Shares
107,050
Price
$0.00
Value
$0
Kiniksa Pharmaceuticals, Ltd.
KNSA
Type
Conversion
Shares
6,392
Price
$0.00
Value
$0
Kiniksa Pharmaceuticals, Ltd.
KNSA
Type
Conversion
Shares
107,050
Price
$0.00
Value
$0
Kiniksa Pharmaceuticals, Ltd.
KNSA
Type
Conversion
Shares
6,392
Price
$0.00
Value
$0
Kiniksa Pharmaceuticals, Ltd.
KNSA
Type
Purchase
Shares
6,392
Price
$15.64
Value
$100K
AI Agent
Try asking...